BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 11568988)

  • 1. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition.
    Kosorok MR; Zeng L; West SE; Rock MJ; Splaingard ML; Laxova A; Green CG; Collins J; Farrell PM
    Pediatr Pulmonol; 2001 Oct; 32(4):277-87. PubMed ID: 11568988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors.
    West SE; Zeng L; Lee BL; Kosorok MR; Laxova A; Rock MJ; Splaingard MJ; Farrell PM
    JAMA; 2002 Jun; 287(22):2958-67. PubMed ID: 12052125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudomonas aeruginosa serological analysis in young children with cystic fibrosis diagnosed through newborn screening.
    Hayes D; Farrell PM; Li Z; West SE
    Pediatr Pulmonol; 2010 Jan; 45(1):55-61. PubMed ID: 20025049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships among health-related quality of life, pulmonary health, and newborn screening for cystic fibrosis.
    Tluczek A; Becker T; Laxova A; Grieve A; Gilles CNR; Rock MJ; Gershan WM; Green CG; Farrell PM
    Chest; 2011 Jul; 140(1):170-177. PubMed ID: 21106659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis.
    Kosorok MR; Jalaluddin M; Farrell PM; Shen G; Colby CE; Laxova A; Rock MJ; Splaingard M
    Pediatr Pulmonol; 1998 Aug; 26(2):81-8. PubMed ID: 9727757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis.
    Li Z; Kosorok MR; Farrell PM; Laxova A; West SE; Green CG; Collins J; Rock MJ; Splaingard ML
    JAMA; 2005 Feb; 293(5):581-8. PubMed ID: 15687313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Segregation of children with CF diagnosed via newborn screening and acquisition of Pseudomonas aeruginosa.
    McKay KO; Cooper PJ; van Asperen PP
    J Cyst Fibros; 2009 Dec; 8(6):400-4. PubMed ID: 19716353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination of cystic fibrosis patients against Pseudomonas aeruginosa reduces the proportion of patients infected and delays time to infection.
    Lang AB; Rüdeberg A; Schöni MH; Que JU; Fürer E; Schaad UB
    Pediatr Infect Dis J; 2004 Jun; 23(6):504-10. PubMed ID: 15194830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal pulmonary status of cystic fibrosis children with meconium ileus.
    Li Z; Lai HJ; Kosorok MR; Laxova A; Rock MJ; Splaingard ML; Farrell PM
    Pediatr Pulmonol; 2004 Oct; 38(4):277-84. PubMed ID: 15334503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and laboratory correlations in patients with cystic fibrosis and Pseudomonas aeruginosa infection: The experience of a regional centre.
    Smădeanu R; Moşescu S; Zăpucioiu C; Orăşeanu D
    Pneumologia; 2016; 65(4):201-6. PubMed ID: 29542902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple antibiotic-resistant Pseudomonas aeruginosa and lung function decline in patients with cystic fibrosis.
    Ren CL; Konstan MW; Yegin A; Rasouliyan L; Trzaskoma B; Morgan WJ; Regelmann W;
    J Cyst Fibros; 2012 Jul; 11(4):293-9. PubMed ID: 22445849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-Revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection.
    Quittner AL; Modi AC; Wainwright C; Otto K; Kirihara J; Montgomery AB
    Chest; 2009 Jun; 135(6):1610-1618. PubMed ID: 19447923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomonas aeruginosa in children with cystic fibrosis diagnosed through newborn screening: assessment of clinic exposures and microbial genotypes.
    Hayes D; West SE; Rock MJ; Li Z; Splaingard ML; Farrell PM
    Pediatr Pulmonol; 2010 Jul; 45(7):708-16. PubMed ID: 20575089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serology as a diagnostic tool for predicting initialPseudomonas aeruginosa acquisition in children with cystic fibrosis.
    Daines C; VanDeVanter D; Khan U; Emerson J; Heltshe S; McNamara S; Anstead M; Langkamp M; Doring G; Ratjen F; Ramsey B; Gibson RL; Morgan W; Rosenfeld M;
    J Cyst Fibros; 2014 Sep; 13(5):542-9. PubMed ID: 25027419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection, inflammation, and lung function decline in infants with cystic fibrosis.
    Pillarisetti N; Williamson E; Linnane B; Skoric B; Robertson CF; Robinson P; Massie J; Hall GL; Sly P; Stick S; Ranganathan S;
    Am J Respir Crit Care Med; 2011 Jul; 184(1):75-81. PubMed ID: 21493738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of birth order and age at diagnosis in cystic fibrosis: a sibling cohort study.
    Slieker MG; van den Berg JM; Kouwenberg J; van Berkhout FT; Heijerman HG; van der Ent CK
    Pediatr Pulmonol; 2010 Jun; 45(6):601-7. PubMed ID: 20503286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis.
    Farrell PM; Shen G; Splaingard M; Colby CE; Laxova A; Kosorok MR; Rock MJ; Mischler EH
    Pediatrics; 1997 Nov; 100(5):E2. PubMed ID: 9346996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by three different serological methods.
    Pressler T; Karpati F; Granström M; Knudsen PK; Lindblad A; Hjelte L; Olesen HV; Meyer P; Høiby N;
    J Cyst Fibros; 2009 Jan; 8(1):37-42. PubMed ID: 18835753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline characteristics and factors associated with nutritional and pulmonary status at enrollment in the cystic fibrosis EPIC observational cohort.
    Rosenfeld M; Emerson J; McNamara S; Joubran K; Retsch-Bogart G; Graff GR; Gutierrez HH; Kanga JF; Lahiri T; Noyes B; Ramsey B; Ren CL; Schechter M; Morgan W; Gibson RL;
    Pediatr Pulmonol; 2010 Sep; 45(9):934-44. PubMed ID: 20597081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age of Pseudomonas aeruginosa acquisition and subsequent severity of cystic fibrosis lung disease.
    Pittman JE; Calloway EH; Kiser M; Yeatts J; Davis SD; Drumm ML; Schechter MS; Leigh MW; Emond M; Van Rie A; Knowles MR
    Pediatr Pulmonol; 2011 May; 46(5):497-504. PubMed ID: 21194167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.